See analyst estimates and all valuation multiples for Health & Beauty
Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
$398B | 4.7x | 17.1x | |
$397B | 6.9x | 15.3x | |
$242B | 4.9x | 20.6x | |
$178B | 2.6x | 12.5x | |
$78.4B | 3.9x | 15.8x | |
$63.6B | 8.6x | 37.5x | |
$63.3B | 1.2x | 5.7x | |
$58.0B | 3.9x | 15.4x | |
$54.3B | 2.9x | 10.1x | |
$53.2B | 3.4x | 14.6x | |
$51.2B | 2.6x | 12.7x | |
$48.6B | 5.4x | 22.3x | |
$32.4B | 1.3x | 7.5x | |
$30.3B | 2.1x | 15.2x | |
$30.3B | 6.3x | 27.4x | |
$27.9B | 2.5x | 14.3x | |
$24.3B | 4.0x | 17.3x | |
$22.3B | 1.5x | 8.2x | |
$22.1B | 2.2x | 6.5x | |
$20.2B | 1.8x | 12.2x | |
$19.8B | 1.7x | 11.1x | |
$15.2B | 8.9x | 42.5x | |
$12.3B | 2.2x | 15.7x | |
$12.2B | 1.8x | 9.5x | |
$11.8B | 8.0x | 30.4x | |
$11.8B | 2.1x | 10.7x | |
$10.8B | 8.4x | 42.5x | |
$10.0B | 11.8x | 27.3x | |
$9.6B | 6.5x | 34.9x | |
$8.5B | 1.3x | 12.0x | |
$8.4B | 1.4x | 7.7x | |
$8.1B | 11.2x | 34.6x | |
$6.8B | 1.6x | 9.2x | |
$6.0B | 2.3x | 10.3x | |
$5.3B | 11.9x | 39.0x | |
$5.2B | 4.6x | 14.0x | |
$5.2B | 10.0x | 40.6x | |
$5.2B | 1.8x | 13.3x | |
$4.9B | 3.1x | 16.7x | |
$4.6B | 3.5x | 15.9x | |
$4.6B | 1.3x | 7.5x | |
$4.2B | 2.0x | 13.5x | |
$4.0B | 2.7x | 13.3x | |
$3.6B | 1.7x | 9.6x | |
$3.6B | 3.5x | 23.6x | |
$3.2B | 4.6x | 20.8x | |
$3.2B | 3.1x | 14.1x | |
$3.1B | 1.0x | 5.9x | |
$3.1B | 0.6x | 5.7x | |
$3.1B | 6.9x | 25.0x | |
$3.0B | 0.6x | 5.9x | |
$3.0B | 8.9x | 35.7x | |
$2.9B | 4.7x | 23.0x | |
$2.7B | 1.2x | 7.8x | |
$2.6B | 1.2x | 10.4x | |
$2.5B | 0.9x | 7.5x | |
$2.5B | 1.0x | 5.1x | |
$2.3B | 0.7x | 4.9x | |
$2.2B | 1.9x | -61.5x | |
$2.2B | 2.7x | 17.8x | |
$2.1B | 1.1x | 9.4x | |
$2.0B | 3.4x | 20.5x | |
$1.9B | 1.2x | 10.1x | |
$1.8B | 4.6x | 13.0x | |
$1.8B | 3.2x | 15.6x | |
$1.7B | 0.9x | 6.0x | |
$1.6B | 0.7x | 7.8x | |
$1.5B | 1.3x | 9.3x | |
$1.4B | 1.9x | 10.4x | |
$1.4B | 1.2x | 9.6x | |
$1.4B | 0.7x | 5.8x | |
$1.4B | 2.5x | 9.8x | |
$1.4B | 4.8x | 11.0x | |
$1.1B | 1.6x | 6.3x | |
$1.0B | 1.5x | 10.7x | |
$956M | 7.1x | 26.7x | |
$921M | 2.2x | 8.0x | |
$908M | 3.7x | 108.7x | |
$755M | n/a | n/a | |
$731M | n/a | n/a | |
$715M | 2.4x | -238.0x | |
$679M | 1.5x | 7.1x | |
$631M | 0.9x | 6.5x | |
$605M | 0.9x | 4.5x | |
$592M | 0.2x | 1.5x | |
$549M | 2.2x | 9.3x | |
$539M | 1.9x | 12.0x | |
$512M | 1.3x | 19.0x | |
$501M | 0.4x | 4.8x | |
$454M | 0.3x | n/a | |
$454M | 3.1x | 12.3x | |
$450M | n/a | n/a | |
$448M | 2.2x | -30.8x | |
$380M | 1.2x | 25.2x | |
$378M | 1.6x | 18.1x | |
$376M | 1.0x | 6.5x | |
$374M | n/a | n/a | |
$362M | n/a | n/a | |
$320M | n/a | n/a | |
$309M | n/a | n/a | |
$301M | n/a | n/a | |
$297M | 0.8x | 9.1x | |
$256M | 5.4x | 20.0x | |
$231M | 1.2x | 7.3x | |
$205M | 0.4x | 9.8x | |
$180M | n/a | n/a | |
$179M | 0.9x | 9.5x | |
$177M | 0.6x | 7.3x | |
$157M | 2.4x | 10.9x | |
$144M | 0.6x | 6.4x | |
$140M | 2.4x | 7.6x | |
$118M | n/a | n/a | |
$103M | n/a | n/a | |
$40.5M | 1.6x | 6.7x | |
$36.4M | n/a | n/a | |
$31.7M | 0.7x | 4.9x | |
$28.7M | n/a | n/a | |
$27.6M | n/a | n/a | |
$22.3M | 1.7x | n/a | |
$20.4M | 0.9x | -80.5x | |
$18.2M | n/a | n/a | |
$17.1M | n/a | n/a | |
$10.8M | n/a | n/a | |
$5.8M | n/a | n/a | |
$0.7M | n/a | n/a | |
$0.6M | n/a | n/a | |
-$10.2M | -0.0x | -0.4x | |
-$24.4M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty